drugset / Trial / NCT05085808

RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium (TraQ)

NCT05085808

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to evaluate the effectiveness of trazodone as compared to quetiapine and placebo, in the management of ICU delirium in adult (\>=18 years old) surgical ICU patients. The investigators will compare outcomes such as delirium incidence and duration, in-hospital mortality, 28-day mortality, hospital length of stay (LOS), ICU LOS, mechanical ventilator days, complications, adverse effects, rescue medication use, delirium symptom severity, sleep duration, and sleep quality among participants receiving trazodone, quetiapine, or placebo. The investigators hypothesize participants receiving trazodone will have a shorter duration of delirium, decreased delirium severity, and improved sleep quality compared to participants receiving quetiapine and placebo.

Timeline

Start
2028-03-01
Primary completion
2029-07-01
Completion
2030-12-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Quetiapine Small molecule 25 mg Oral
Subject Trazodone Small molecule 25 mg Oral

Indications